glp-1 and type 1 diabetes GLP-1-based therapies for 2 diabetes: from single, dual triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome More people with type 1

WHO CAN TAKE SEMAGLUTIDE

I do not think people should be eating 800 to 1000 calories a day and exercising 7 days a week

Pioglitazone does not induce hypoglycaemia episodes, it improves the lipid profile and has demonstrated certain cardiovascular benefits and a renoprotective effect in CKD patients.81 Its use is associated with sodium and water retention, oedema and an increased risk of heart failure,82 limiting its use in CKD patients

There are legitimate medical uses for peptides GLP-1 drugs, for instance but the stuff getting hawked on eBay requires no prescription and seems to have no regulatory oversight whatsoever